PedAM
Pediatric Disease Annotations & Medicines
| Disease | hyperuricemia |
| Phenotype | C0018801|heart failure |
| Sentences | 7 |
| PubMedID- 25197282 | In patients without ra, hyperuricemia was associated with heart failure (hr: 1.95; 95% ci: 1.13-3.39) and cvd (hr: 1.59; 95% ci: 0.99-2.55). |
| PubMedID- 23566246 | hyperuricemia in patients with heart failure is associated with higher levels of serum markers of inflammation (c-reactive protein [crp], il-6, and neutrophil count) [33] and higher levels of markers of endothelial activation, such as the soluble intercellular adhesion molecule-1, and inflammatory markers such as il-6, tnf-α, and its receptors [34,35]. |
| PubMedID- 23659064 | Prognostic significance of hyperuricemia in patients with chronic heart failure is discussed. |
| PubMedID- 23395281 | Prednisone in uric acid lowering in symptomatic heart failure patients with hyperuricemia (push-path) study. |
| PubMedID- 25774058 | Prednisone in uric acid lowering in symptomatic heart failure patients with hyperuricemia -- the push-path3 study. |
| PubMedID- 26297226 | Relationship of hyperuricemia with mortality in heart failure patients with preserved ejection fraction. |
| PubMedID- 23607043 | Indeed, few studies have investigated the association of hyperuricemia with subclinical heart failure and atherosclerosis [12–15]. |
Page: 1